Cellworks Group Inc.   Report issue

For profit
Founded: San Jose CA United States (2005)
Status: Left NME R&D (2023)

Organization Overview

First Clinical Trial
2018
NCT03446638
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Cellworks Group Inc.

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 5